Plasma nortriptyline levels--relationship to clinical effects.
D000275:Adjustment Disorders / Q000175:diagnosis; D000928:Antidepressive Agents / Q000627:therapeutic use; D001798:Blood Proteins / Q000378:metabolism; D002986:Clinical Trials as Topic; D003863:Depression / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy*; D003937:Diagnosis, Differential; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007498:Iris / Q000378:metabolism; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D009661:Nortriptyline / Q000009:adverse effects / Q000097:blood* / Q000627:therapeutic use; D010919:Placebos; D011485:Protein Binding; D011569:Psychiatric Status Rating Scales; D012702:Serotonin Antagonists; D013997:Time Factors; D014786:Vision Disorders / Q000139:chemically induced
D000928:Antidepressive Agents; D001798:Blood Proteins; D010919:Placebos; D012702:Serotonin Antagonists; D009661:Nortriptyline; D009638:Norepinephrine